Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Venlafaxine Hydrochloride × Clear all

NCT05724849 2024-01-18

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Phase 2 Withdrawn

Depression, Head and Neck Neoplasms